Sponsor or institution
Clinical trials and research at Virtici, LLC
As of November 12, 2026, Find a Trial lists 14 NIH-funded research projects at this institution, with $7.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14NIH research projects
NIH-funded research (14)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new sublingual vaccine to prevent and treat gum disease
A sublingual vaccine is being developed to prevent and treat periodontitis caused by specific gum pathogens, with the goal of reducing gum inflammation, tooth loss, and related health risks.
-
New anti-infective therapy to treat gum disease
A new targeted medicine would help people with periodontitis by aiming at the bacteria that drive gum disease.
-
Bispecific antibody therapy for idiopathic pulmonary fibrosis (IPF)
A new antibody therapy called VTC-890 is being developed to block two inflammatory signals in IPF to slow lung scarring.
-
A probiotic-based therapy to reset immune function in rheumatoid arthritis
A new orally taken therapy aims to restore immune balance in people with rheumatoid arthritis to help achieve long-term remission.
-
Orally delivered immune-modulating probiotic for rheumatoid arthritis
A new oral therapy using a probiotic approach aims to help people with rheumatoid arthritis achieve long-term remission.
-
Oral peptide to prevent and treat P. gingivalis-related gum disease
An oral peptide medicine is being developed to stop and treat gum infections and periodontitis caused by P. gingivalis in adults.
-
Oral probiotic therapy to prevent and treat Klebsiella infections
A new oral probiotic medicine is being developed to prevent and treat gut colonization and infections caused by Klebsiella pneumoniae, a dangerous hospital-associated bacterium.
-
A new treatment for Idiopathic Pulmonary Fibrosis using a bispecific antibody.
This study is testing a new treatment called VTC-890 that aims to help people with Idiopathic Pulmonary Fibrosis by blocking two proteins that cause lung scarring, with the hope of improving their breathing and overall health.
-
A new blood test to diagnose Frontotemporal Lobar Degeneration early
This study is working on a new blood test to help diagnose Frontotemporal Lobar Degeneration (FTD) early and easily, so that people under 65 can get the answers they need faster and start getting the right support.
-
A new antibody to support brain health and growth in Alzheimer's patients
This study is testing a new treatment that uses a special type of antibody to help protect brain cells and encourage the growth of new ones in people with Alzheimer's Disease, with the hope of improving brain function and reducing harmful proteins.
-
A new sublingual vaccine to prevent gonorrhea infections
This study is testing a new vaccine that you can take under your tongue to help protect against gonorrhea, aiming to boost your immune system's ability to fight off the infection, especially as some treatments are becoming less effective.
-
Developing a new oral treatment to prevent gum infections caused by P. gingivalis
This study is testing a new oral treatment that could help fight gum diseases by stopping harmful bacteria from sticking around in your mouth, and it’s looking for patients to help see how well it works and if it’s safe.
-
A new antibody to help protect brain cells and promote new brain cell growth for Alzheimer's disease treatment
This study is testing a new type of treatment for Alzheimer's disease that uses special antibodies to help protect and support brain cells, with the hope of reducing harmful substances in the brain, and patients may have the chance to participate in trials to see how well it works.
-
Developing a probiotic to help treat asthma by inducing tolerance to allergens
This study is testing a new probiotic called VTC-L35 that aims to help people with asthma feel better by teaching their bodies to handle certain allergens that make them sick, offering a friendlier way to manage asthma without just relying on regular medications.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.